Delcath Systems :
DCTH
DCTH
Stock Data
$10.80
$0.42 (4.05%)
Asset Type
Common Stock
Exchange
NASDAQ
Currency
USD
Country
USA
Sector
HEALTHCARE
Industry
MEDICAL DEVICES
Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company is headquartered in New York, New York.
All Delcath Systems Articles
12 Articles